Alici E - Search Results

1

Suicide gene therapy for graft-versus-host disease.

Georgoudaki AM, Sutlu T, Alici E. Georgoudaki AM, et al. Among authors: alici e. Immunotherapy. 2010 Jul;2(4):521-37. doi: 10.2217/imt.10.19. Immunotherapy. 2010. PMID: 20636006 Review.

2

Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.

Alici E, Konstantinidis KV, Sutlu T, Aints A, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Exp Hematol. 2007 Dec;35(12):1839-46. doi: 10.1016/j.exphem.2007.08.006. Exp Hematol. 2007. PMID: 18036444 Free article.

3

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E, Sutlu T, Björkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Blood. 2008 Mar 15;111(6):3155-62. doi: 10.1182/blood-2007-09-110312. Epub 2008 Jan 11. Blood. 2008. PMID: 18192509 Free article.

4

The prognostic significance of 8p21 deletion in multiple myeloma.

Sutlu T, Alici E, Jansson M, Wallblom A, Dilber MS, Gahrton G, Nahi H. Sutlu T, et al. Among authors: alici e. Br J Haematol. 2009 Jan;144(2):266-8. doi: 10.1111/j.1365-2141.2008.07454.x. Epub 2008 Nov 11. Br J Haematol. 2009. PMID: 19016723 Free article. No abstract available.

5

Retroviral gene transfer into primary human natural killer cells.

Alici E, Sutlu T, Sirac Dilber M. Alici E, et al. Methods Mol Biol. 2009;506:127-37. doi: 10.1007/978-1-59745-409-4_10. Methods Mol Biol. 2009. PMID: 19110624

6

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E, Sutlu T, Deneberg S, Alici E, Björkstrand B, Jansson M, Lerner R, Wallblom A, Gahrton G, Nahi H. Paul E, et al. Among authors: alici e. Oncol Rep. 2009 Jul;22(1):137-42. doi: 10.3892/or_00000416. Oncol Rep. 2009. PMID: 19513515

7

Natural killer cell-based immunotherapy in cancer: current insights and future prospects.

Sutlu T, Alici E. Sutlu T, et al. Among authors: alici e. J Intern Med. 2009 Aug;266(2):154-81. doi: 10.1111/j.1365-2796.2009.02121.x. J Intern Med. 2009. PMID: 19614820 Free article. Review.

8

Constitutional inv(3) in myelodysplastic syndromes.

Gahrton C, Nahi H, Jansson M, Wallblom A, Alici E, Sutlu T, Samuelsson J, Gahrton G. Gahrton C, et al. Among authors: alici e. Leuk Res. 2010 Dec;34(12):1627-9. doi: 10.1016/j.leukres.2010.05.014. Epub 2010 Jun 9. Leuk Res. 2010. PMID: 20542563

9

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.

Barkholt L, Alici E, Conrad R, Sutlu T, Gilljam M, Stellan B, Christensson B, Guven H, Björkström NK, Söderdahl G, Cederlund K, Kimby E, Aschan J, Ringdén O, Ljunggren HG, Dilber MS. Barkholt L, et al. Among authors: alici e. Immunotherapy. 2009 Sep;1(5):753-64. doi: 10.2217/imt.09.47. Immunotherapy. 2009. PMID: 20636021 Clinical Trial.

10

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.

Sutlu T, Stellan B, Gilljam M, Quezada HC, Nahi H, Gahrton G, Alici E. Sutlu T, et al. Among authors: alici e. Cytotherapy. 2010 Dec;12(8):1044-55. doi: 10.3109/14653249.2010.504770. Epub 2010 Aug 26. Cytotherapy. 2010. PMID: 20795758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page